1-Methylpyrrolidin-3-amine dihydrochloride, 95.0%, 25g

1-((4-chloro-3-(trifluoromethyl)phenyl)sulfonamido)cyclohexane-1-carboxylic acid, 95.0%, 500mg

(S)-2-Aminooctanedioic acid, 95.0%, 100mg

4-(Benzo[d]thiazol-2-ylthio)morpholine, 95.0%, 500g

3-Bromo-4'-fluorodiphenyl ether, 97.0%, 1g

Ethyl 2-(1,3,2-dioxaborinan-2-yl)benzoate, 96%, 5g

Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate, 98.0%, 25g

2-Phenylsulfonylacetophenone>98.0%(GC)(T)5g

5-(2,5-Dioxotetrahydrofurfuryl)-3-methyl-3-cyclohexene-1,2-dicarboxylic acid acid anhydride, 95.0%, 100g

Colonna capillare per GC ROTI®Cap-5, 25 m, 0.32 mm, 1.00 µm, 1 Pezzo(i)

N-(2-Morpholinoethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95.0%, 5g

4-(Piperidin-1-yl)benzene-1-carbothioamide, 98%, 5g

2-FURANCARBOXYLIC ACID, 5-METHYL-, ETHYL ESTER, 95.0%, 250mg